Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Katherine Shing-Faye Tzou

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-RADONC General Operations

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E, Kendi AT, Tzou K, Quevedo F, Choo R, Moore CN, Ho TH, Singh P, Keole SR, Wong WW, Sartor O, Bryce AH. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. Prostate. 2022 09; 82(12):1202-1209. PMID: 35652618.
      View in: PubMed
    2. Malouff TD, Vallow LA, Magalhaes WL, Seneviratne DS, Waddle MR, Tzou KS. Dosimetric Analysis of Axillary Lymph Node Coverage Using High Tangents in the Prone Position for Left-Sided Breast Cancers. Cureus. 2022 Mar; 14(3):e23613. PMID: 35505718.
      View in: PubMed
    3. Shaw P, Raymond G, Tzou KS, Baxi S, Mani RR, Kumar Govind S, Chandramoorthy HC, Sivanandy P, Rajagopal M, Samiappan S, Krishnan S, Jayaraj R. Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis. Genes (Basel). 2022 01 08; 13(1). PMID: 35052456.
      View in: PubMed
    4. Wiest NE, Tzou KS, Olson MT, Herchko SM, Bajalia EM, Thiel DD, Lou Y, Zhao Y, Manochakian R. Crizotinib-associated renal cyst development may be associated with prolonged progression-free survival in patients with ALK-positive non-small-cell lung cancer: Case report and review of the literature. Clin Case Rep. 2021 Jun; 9(6):e04278. PMID: 34136235.
      View in: PubMed
    5. Jayaraj R, Raymond G, Krishnan S, Tzou KS, Baxi S, Ram MR, Govind SK, Chandramoorthy HC, Abu-Khzam FN, Shaw P. Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2020 May 09; 12(5). PMID: 32397507.
      View in: PubMed
    6. Malouff TD, Seneviratne D, Stross WC, Ko S, Tzou K, Trifiletti DM, Vallow LA. Public interest in stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) in the United States. J Radiosurg SBRT. 2020; 6(4):311-315. PMID: 32185091.
      View in: PubMed
    7. Ruiz-Garcia H, Marenco-Hillembrand L, Peterson JL, Tzou K, Malouff TD, Chaichana KL, Trifiletti DM, Vallow L. The management of elderly patients with brain metastases from breast cancer. Transl Cancer Res. 2020 Jan; 9(Suppl 1):S62-S76. PMID: 35117949.
      View in: PubMed
    8. Malouff TD, Stross WC, Seneviratne DS, Waddle MR, May BC, Buskirk SJ, Tzou KS. Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis. Prostate Cancer Prostatic Dis. 2020 06; 23(2):349-355. PMID: 31780782.
      View in: PubMed
    9. Leon J, Trifiletti DM, Waddle MR, Vallow L, Ko S, May B, Tzou K, Ruiz-Garcia H, Lundy L, Chaichana K, Vibhute P, Peterson JL. Trends in the initial management of vestibular schwannoma in the United States. J Clin Neurosci. 2019 Oct; 68:174-178. PMID: 31324471.
      View in: PubMed
    10. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 01; 59(suppl_1):i19-i24. PMID: 29538757.
      View in: PubMed
    11. Hintenlang LL, Miller DH, Kaleem T, Patel N, May BC, Tzou KS, Vallow LA, Buskirk SJ, Miller RC, Ko SJ, Jaeckle KA, Trifiletti DM, Peterson JL. Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature. J Clin Neurosci. 2018 Feb; 48:118-121. PMID: 29183682.
      View in: PubMed
    12. Robinson JL, Tzou KS, Parker AS, Heckman MG, Wu KJ, Hilton TW, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Buskirk SJ. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer. Br J Radiol. 2017 Jul; 90(1075):20170174. PMID: 28486040.
      View in: PubMed
    13. Wong WW, Anderson EM, Mohammadi H, Daniels TB, Schild SE, Keole SR, Choo CR, Tzou KS, Bryce AH, Ho TH, Quevedo FJ, Vora SA. Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 12; 15(6):e969-e975. PMID: 28545997.
      View in: PubMed
    14. Habboush Y, Shannon RP, Niazi SK, Hollant L, Single M, Gaines K, Smart B, Chimato NT, Heckman MG, Buskirk SJ, Vallow LA, Tzou KS, Ko SJ, Peterson JL, Biers HA, Day AB, Nelson KA, Sloan JA, Halyard MY, Miller RC. Patient-reported distress and survival among patients receiving definitive radiation therapy. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):211-219. PMID: 28740934.
      View in: PubMed
    15. Whitaker DA, Miller DH, Jagadesh N, Strong GW, Hintenlang L, Schenk WB, Broderick GA, Tzou KS, Buskirk SJ. Small Cell Carcinoma of the Prostate in an Elderly Patient: A Case Report and Review of the Literature. Rare Tumors. 2016 Nov 17; 8(4):6657. PMID: 28191295.
      View in: PubMed
    16. Stish BJ, Pisansky TM, Harmsen WS, Davis BJ, Tzou KS, Choo R, Buskirk SJ. Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer. J Clin Oncol. 2016 11 10; 34(32):3864-3871. PMID: 27480153.
      View in: PubMed
    17. Joseph RW, Cappel M, Tzou K, Bagaria S, Gilstrap C, Swaika A, Jambusaria-Pahlajani A. Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod. Melanoma Res. 2016 08; 26(4):409-12. PMID: 27138458.
      View in: PubMed
    18. Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ. An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. PLoS One. 2016; 11(3):e0151785. PMID: 26986977.
      View in: PubMed
    19. Miller DH, Peterson JL, Buskirk SJ, Vallow LA, Ta R, Joseph R, Krishna M, Ko SJ, Tzou KS. Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation. Rare Tumors. 2015 Sep 07; 7(3):6082. PMID: 26500736.
      View in: PubMed
    20. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int. 2016 08; 118(2):236-42. PMID: 26190356.
      View in: PubMed
    21. Peterson JL, Buskirk SJ, Heckman MG, Diehl NN, Bernard JR, Tzou KS, Casale HE, Bellefontaine LP, Serago C, Kim S, Vallow LA, Daugherty LC, Ko SJ. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity. Med Dosim. 2014; 39(1):12-7. PMID: 24099966.
      View in: PubMed
    22. Heckman MG, Tzou KS, Parker AS, Pisansky TM, Schild SE, Hilton TW, Patel VN, Pelaez L, Khor LY, Peterson JL, Daugherty LC, Vallow LA, Pollack A, Buskirk SJ. Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer. J Radiat Oncol. 2013 Sep 01; 2(3):309-314. PMID: 24073305.
      View in: PubMed
    23. Peterson JL, Vallow LA, Johnson DW, Heckman MG, Diehl NN, Smith AA, Tzou KS, Paz-Fumagalli R, Kim S, Ko SJ, Daugherty LC, Kim GP, Brown N, Mori KW, Buskirk SJ. Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy. 2013 Nov-Dec; 12(6):573-9. PMID: 23953810.
      View in: PubMed
    24. Peterson JL, Buskirk SJ, Heckman MG, Parker AS, Diehl NN, Tzou KS, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Pisansky TM. Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer. ISRN Oncol. 2013; 2013:239241. PMID: 23606986.
      View in: PubMed
    25. Lee RJ, Vallow LA, McLaughlin SA, Tzou KS, Hines SL, Peterson JL. Ductal carcinoma in situ of the breast. Int J Surg Oncol. 2012; 2012:123549. PMID: 22852075.
      View in: PubMed
    26. Tzou K, Tan WW, Buskirk S. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Expert Rev Anticancer Ther. 2011 Jan; 11(1):125-36. PMID: 21166517.
      View in: PubMed
    27. Clarke JW, Hadziahmetovic M, Tzou K, Lau CC, Paulino AC, Grecula JC, Montebello JF, Mayr NA, Lo SS. What is the best adjuvant treatment for very young patients with medulloblastoma? Expert Rev Neurother. 2007 Apr; 7(4):373-81. PMID: 17425492.
      View in: PubMed
    28. Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer Res. 2004 Nov 01; 64(21):8062-7. PMID: 15520217.
      View in: PubMed
    Tzou's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)